St. Galler Kantonalbank AG (0QQZ)
London Exchange · UK · prices in GBP · close of 19 Oct 2026
Key indicators
| Last close | GBP 697.00 |
|---|---|
| 52-week range | 499.84 – 720.00 |
| Return, 1 month / 3 months | +1.6% / +4.2% |
| Return, 1 year / 3 years | +38.3% / +43.0% |
| Trend | Uptrend |
| RSI (14) | 51 |
| Volatility (1 year) | 16.4% |
| Worst drawdown (1 year) | -12.6% |
| Average daily value traded | 0.99M GBP |
| Dividend yield | 0.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
St. Galler Kantonalbank is a Swiss cantonal bank based in the city of St. Gallen. It serves private individuals and businesses in its home region, offering savings and deposit accounts, mortgages and other lending, payment services, and investment advice, along with financing and advisory services for small and medium-sized companies. The bank also provides wealth management and private banking services to more affluent clients, and it operates through a network of branches across the canton and neighbouring areas.
On this site St. Galler Kantonalbank AG appears as a stock on the London Exchange (UK), code 0QQZ, with prices in pounds sterling (GBP). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
St. Galler Kantonalbank AG (0QQZ) trades on the London Exchange in UK. It last closed at GBP 697.00 on 19 October 2026.
Its price-based Market X-Ray is 70 out of 100 (a fair price profile), ranking 526 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 38.3% and over the last three months it rose 4.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 75 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 8.2% | ||
| From 52-week high | -2.4% | ||
| Momentum | 70 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 4.2% | ||
| 6-month return | 6.9% | ||
| 12-month return, skipping the last month | 36.1% | ||
| Stability (higher is calmer) | 92 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 16.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -12.6% | ||
| Liquidity | 52 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.99M GBP | ||
| Zero-volume days | 1.7% | ||
| Income | 27 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.0% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −0.9% |
|---|---|
| 1 month | +1.6% |
| 3 months | +4.2% |
| 6 months | +6.9% |
| 1 year | +38.3% |
| 3 years | +43.0% |
| 5 years | – |
Signals
| 50-day / 200-day average | 675.74 / 643.92 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 9.44 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 1 May 2026 | GBX 0.2000 |
| 5 May 2025 | GBX 0.0735 |
| 3 May 2024 | GBX 0.0700 |
| 5 May 2023 | GBX 0.1700 |
| 6 May 2022 | GBX 0.1700 |
| 7 May 2021 | GBX 0.1600 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.